AddLife acquires Camanio AB

Camanio is a Swedish provider of digital health and care services with a turnover of approximately SEK 13 million and 18 employees

AddLife acquires Fischer Medical ApS

Fischer Medical is a distributor specialized in advanced surgery in Denmark and Sweden with revenues of approximately SEK 60 million

AddLife acquires Healthcare 21 Group

Bio-Connect is a distributor with operations in the Benelux countries in Life Science and Diagnostics, and has a turnover of approximately EUR 14 million

Acquisition in ophthalmology

Expansion in new segment through acquisition of Vision Ophthalmology Group

Allbright Report 2021

Thank you for awarding AddLife as one of Sweden's most equal listed companies.
AddLife has placed on Allbright's green stock exchange list 2021 with an even gender distribution in the management group (40/60).


Another strong quarter

Interim Report Q3 2021

After almost two years of the COVID-19 pandemic, our communities are starting to re-open. The business situation in the third quarter remained favourable, influenced by the efforts of the different countries to manage the infection. Sales in the third quarter increased by 49 percent to SEK 1,850 million and the result, EBITA, increased by 44 percent to SEK 286 million and the EBITA margin amounted to 15.5 percent. Accumulated for the interim period, sales increased by 65 percent to SEK 5,862 million and EBITA rose by 94 percent to SEK 944 million.


Labtech offers products, solutions and a broad range of services in diagnostics, biomedical research and laboratory analysis.



Medtech offers products, solutions and services in medtech and home care.



We develop your company through active ownership. AddLife acquires companies in order to maintain and further develop them in the long term.



Our vision is to improve people's lives, for example by sponsoring: